Clincosm LogoSign in Get a demo

Myelodysplastic Syndrome (MDS)

Showing NaN - NaN of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Myelodysplastic Syndrome (MDS) Trial in United States (MBG453, Azacitidine, Decitabine)

Recruiting
  • Myelodysplastic Syndrome (MDS)
  • Chandler, Arizona
  • +22 more
Dec 5, 2022

Myelodysplastic Syndrome (MDS) Trial in Worldwide (Venetoclax, Azacitidine, Placebo)

Active, not recruiting
  • Myelodysplastic Syndrome (MDS)
  • Fullerton, California
  • +219 more
Aug 24, 2022

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in United States (Infusion of NEXI-001 T Cells)

Recruiting
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Infusion of NEXI-001 T Cells
  • Duarte, California
  • +4 more
Feb 16, 2021

Myelodysplastic Syndrome (MDS), Chronic Lymphocytic Leukemia (CLL), Chemo-sensitive Lymphoma Trial in United States (drug,

Completed
  • Myelodysplastic Syndrome (MDS)
  • +6 more
  • Gainesville, Florida
  • +10 more
Nov 30, 2020

Hematological Malignancies, Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML) Trial in Worldwide (NiCord®)

Completed
Has Results
  • Hematological Malignancies
  • +3 more
  • Los Angeles, California
  • +14 more
Oct 1, 2020

Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (CliniMACS

Recruiting
  • Chronic Myeloid Leukemia (CML)
  • +5 more
  • CliniMACS CD34+ Reagent System
  • +8 more
  • New York, New York
    Columbia University Medical Center
Jun 17, 2020

Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS) Trial in New York (Laromustine (VNP40101M) and Ara-C)

Terminated
  • Acute Myeloid Leukemia (AML)
  • Myelodysplastic Syndrome (MDS)
  • Laromustine (VNP40101M) and Ara-C
  • New York, New York
    Weill Cornell Medical College
Jan 25, 2019

Myelodysplastic Syndrome (MDS) Trial in New York (T2* Cardiac and Liver MRI)

Completed
  • Myelodysplastic Syndrome (MDS)
  • T2* Cardiac and Liver MRI
  • New York, New York
    Weill Medical College of Cornell University
Oct 23, 2018

Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML) Trial in Worldwide (birinapant, Azacitidine, Placebo)

Terminated
  • Myelodysplastic Syndrome (MDS)
  • Chronic Myelomonocytic Leukemia (CMML)
  • Glendale, Arizona
  • +75 more
Oct 18, 2016

Myelodysplastic Syndrome (MDS) Trial in United States (ezatiostat HCl (Telintra®))

Terminated
  • Myelodysplastic Syndrome (MDS)
  • ezatiostat hydrochloride (Telintra®)
  • Maywood, Illinois
  • +4 more
Nov 20, 2013

Myelodysplastic Syndrome (MDS) Trial in United States (ezatiostat HCl (Telintra®))

Terminated
  • Myelodysplastic Syndrome (MDS)
  • ezatiostat hydrochloride (Telintra®)
  • Concord, California
  • +6 more
Nov 20, 2013

Myelodysplastic Syndrome (MDS) Trial in United States (Ezatiostat Hydrochloride)

Completed
  • Myelodysplastic Syndrome (MDS)
  • Ezatiostat Hydrochloride
  • Tucson, Arizona
  • +35 more
Oct 10, 2011

Myelodysplastic Syndrome (MDS) Trial in United States (lintuzumab, lenalidomide)

Completed
  • Myelodysplastic Syndrome (MDS)
  • Birmingham, Alabama
  • +7 more
Oct 7, 2011